...
首页> 外文期刊>International Journal of Molecular Sciences >The Dichotomic Role of Macrophage Migration Inhibitory Factor in Neurodegeneration
【24h】

The Dichotomic Role of Macrophage Migration Inhibitory Factor in Neurodegeneration

机译:巨噬细胞迁移抑制因子在神经变性中的二分形作用

获取原文
           

摘要

Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine expressed by different cell types and exerting multiple biological functions. It has been shown that MIF may be involved in several disorders, including neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS), Parkinson disease (PD), and Huntington disease (HD), that represent an unmet medical need. Therefore, further studies are needed to identify novel pathogenetic mechanisms that may translate into tailored therapeutic approaches so to improve patients’ survival and quality of life. Here, we reviewed the preclinical and clinical studies investigating the role of MIF in ALS, PD, and HD. The emerging results suggest that MIF might play a dichotomic role in these disorders, exerting a protective action in ALS, a pathogenetic action in HD, and a yet undefined and debated role in PD. The better understanding of the role of MIF in these diseases could allow its use as a novel diagnostic and therapeutic tool for the monitoring and treatment of the patients and for eventual biomarker-driven therapeutic approaches.
机译:巨噬细胞迁移抑制因子(MIF)是由不同细胞类型表达并施加多种生物学功能的脂肪术细胞因子。已经表明,MIF可以参与几种疾病,包括神经变性疾病,例如肌营养的外侧硬化(ALS),帕金森病(PD)和亨廷顿疾病(HD),其代表未满足的医疗需求。因此,需要进一步的研究来识别可以转化为量身定制的治疗方法的新型致病机制,以改善患者的生存和生活质量。在这里,我们回顾了研究MIF在ALS,PD和HD中的作用的临床前和临床研究。新兴的结果表明,MIF可能在这些疾病中发挥二胞体作用,施加ALS的保护作用,HD中的致病作用,以及PD中的尚未确定的和脱象的作用。更好地了解MIF在这些疾病中的作用可以用作用于监测和治疗患者的新型诊断和治疗工具以及最终的生物标志物驱动的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号